First Dedicated Esports Apparel Brand H4X.gg Unveils Its Debut Line of Performance Gear and Streetwear, Partners with ESL and DreamHack
Esports apparel and gear company Moniker, Inc. ("Moniker") has introduced the first esports lifestyle brand H4X.gg (pronounced “hacks”) with high quality performance wear and casual streetwear for esports athletes and fans. H4X.gg has partnered with ESL, the world’s largest esports company, and DreamHack, the world’s largest digital festival, to become the official apparel supplier of ESL One, Intel® Extreme Masters, DreamHack Open, DreamHack Masters and DreamLeague 2018, kicking off with ESL One in Katowice, Poland on February 24-25.
"We are very happy to partner with the first dedicated esports apparel brand designed specifically for fans and players,” said Bernhard Mogk, SVP Global Sales & Business Development at ESL. “We’re incredibly excited to debut the line of performance gear at ESL One Katowice this month and roll out the entire line at future ESL events throughout 2018.”
The H4X.gg line was developed by passionate gamers and esports industry veterans at BITKRAFT Esports Ventures, led by ESL founder Jens Hilgers, and Jon Wayne Gurman, an apparel and manufacturing expert with more than 35 years experience in the fashion and licensing industry.
“Esports fans and players are warriors and athletes and deserve highly technical and practical gear coupled with the spirit and fashion of the lifestyle,” said Jon Gurman, CEO, Moniker. “H4X.gg is inspired by the passion of competitive gamers, and reflects the mindset and aesthetic of esports champions.”
A first look at the debut H4X.gg apparel can be viewed at H4X.gg. The collection will be available online at H4X.gg and through select ESL One, Intel® Extreme Masters (IEM) and DreamHack circuits through 2018.
About Moniker
The company was founded in 2017 by Jon Gurman and BITKRAFT Esports Ventures, through Gurman’s understanding of the apparel and licensing world and the BITKRAFT’s expertise and network in the esports industry. Moniker was founded as a holding company and joint management vehicle for the two parties. It will serve as the umbrella for several esports apparel brands, each targeted at different parts of the market. The first such brand is called H4X.gg and is managed and owned entirely by Moniker. H4X.gg sells casual streetwear and high-quality performance wear for esports athletes and enthusiasts. Moniker is in development with additional brands to live under the esports consumer product umbrella.
About ESL
ESL, a part of the international digital entertainment group MTG, is the world's largest esports company, leading the industry across the most popular video games with numerous online and offline competitions. It operates high profile, branded international and national leagues and tournaments such as the Intel® Extreme Masters, ESL One, ESL National Championships and other top tier stadium-size events, as well as grassroots amateur cups, leagues and matchmaking systems. ESL covers a broad field of services in gaming technology, event management, advertising and television production, fully catering to the needs of the esports ecosystem. With offices in North America, Germany, Russia, France, Poland, Spain, China, and partners in many other countries, it has a truly global footprint. www.eslgaming.com
About DreamHack
DreamHack is the world’s largest digital festival, a meeting place for gamers, with major events hosted each year in Europe and North America. Founded in 1994, DreamHack’s core has always been the LAN party where attendees bring their computer from home and set up for 3 straight days of gaming. DreamHack’s festivals have grown organically over time, becoming a platform for esports, Internet and gaming culture, intellectual and creative competitions, live music acts, lectures by industry experts, celebrity content creators, cosplayers, Expo Hall and much more.
DreamHack is also a production company, creating content focused on gaming, esports, music and arena events, for both traditional Television and digital content networks. In 2017, DreamHack welcomed more than 250,000 visitors to its live events and its online esports broadcasts received more than 375 million views. More information is available at dreamhack.com. DreamHack is part of leading international digital entertainment group MTG. More information at mtg.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180220005667/en/
Contact information
Press Contact
fortyseven communications for Moniker
Craig
Sinel, 323.658.1200
h4x@fortyseven.com
or
Business
Contact
info@moniker.gg
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 23:30:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to existing therapies. Gilteritinib (Xospata®; Astellas Pharma, peak annual sales projection: $1.5 billion) and Quizartinib (Vanflyta®; Daiichi Sankyo) are two FDA-approved FLT3 inhibitors, with the former approved only for relapsed/refractory AML and the latter approved o
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 23:05:00 EEST | Press release
IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global freight industry. “Einride shares our belief that quantum computing will fundamentally reshape and improve how large industries such as transportation and logistics operate,” said Niccolo de Masi, CEO of IonQ. “This partnership is aimed at creating a powerful platform with u
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 22:26:00 EEST | Press release
CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current standard of care for EGFR-positive NSCLC is comprised of 3rd-generation inhibitors, most notably Osimertinib (Tagrisso®), whose annual sales exceed $6 billion. Most patients treated by tyrosine kinase inhibitors (TKIs) will eventually develop
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 22:24:00 EEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 22:08:00 EEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom